<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:314d5b30-630a-4e77-84ce-77d81b4a6ce1,g:2d9ef5c0-0ea2-4603-97ee-37f51e5dcc73,d:d7e1df36290b4c4687476d08e01ce956--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>anab-20230511</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl80L2ZyYWc6M2E5MjM0ZmE2M2EzNDAyMDlkZTg0YTE1MjFiYjgxZGYvdGFibGU6M2I0NTYyMDlkMDVhNDIyY2IyNzc1MjllMjA4ZDlhMmEvdGFibGVyYW5nZTozYjQ1NjIwOWQwNWE0MjJjYjI3NzUyOWUyMDhkOWEyYV8yLTEtMS0xLTc2NjQy_eb1aa51c-59aa-4ceb-83bf-cc609e6116d9">0001370053</ix:nonNumeric><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl80L2ZyYWc6M2E5MjM0ZmE2M2EzNDAyMDlkZTg0YTE1MjFiYjgxZGYvdGFibGU6M2I0NTYyMDlkMDVhNDIyY2IyNzc1MjllMjA4ZDlhMmEvdGFibGVyYW5nZTozYjQ1NjIwOWQwNWE0MjJjYjI3NzUyOWUyMDhkOWEyYV81LTEtMS0xLTc2NjQy_99c92528-a42b-4d1a-90b0-d87baeee78a3">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="anab-20230511.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001370053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-11</xbrli:startDate><xbrli:endDate>2023-05-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id7e1df36290b4c4687476d08e01ce956_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzU3_9508c22b-6450-42c9-ad9e-c2711c1114aa">8-K</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report: <ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xOTE_f61d8d2a-f193-4370-9e8b-59337c8620f6">May 11, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzY0_b0ee5fda-2668-43bb-9b89-45298bfc37ba">ANAPTYSBIO, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.857%"><tr><td style="width:1.0%"></td><td style="width:33.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGFibGU6MzU3YzQzOTE3NGRmNGNiMTllODk5NWQ3MjNmM2Q1NzYvdGFibGVyYW5nZTozNTdjNDM5MTc0ZGY0Y2IxOWU4OTk1ZDcyM2YzZDU3Nl8wLTAtMS0xLTc2NjQy_e7b95f12-8450-4d51-812b-db116bed98a4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGFibGU6MzU3YzQzOTE3NGRmNGNiMTllODk5NWQ3MjNmM2Q1NzYvdGFibGVyYW5nZTozNTdjNDM5MTc0ZGY0Y2IxOWU4OTk1ZDcyM2YzZDU3Nl8wLTEtMS0xLTc2NjQy_748590ea-3629-4a98-89d7-0486adc75df2">001-37985</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGFibGU6MzU3YzQzOTE3NGRmNGNiMTllODk5NWQ3MjNmM2Q1NzYvdGFibGVyYW5nZTozNTdjNDM5MTc0ZGY0Y2IxOWU4OTk1ZDcyM2YzZDU3Nl8wLTItMS0xLTc2NjQy_ca5f2acb-819c-4d6c-9b46-f9e991652833">20-3828755</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzY4_bad89f1a-c3c4-4340-b566-206f7dd05277">10770 Wateridge Circle</ix:nonNumeric>, <ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzYw_a44d3964-8a2c-4bce-b1e4-28aec9cb61e2">Suite 210,</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzYx_3bb15b0c-1969-4c9f-900a-be8ef6f76932">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzY5_bc83198d-fe5b-4918-93ab-666f2eecf2c6">CA</ix:nonNumeric>  <ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzcw_d7e566d7-19d4-473e-b07d-21ec40d7f84f">92121</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, and Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzYy_a5016183-3062-4286-87d9-af13a353a95e">858</ix:nonNumeric>) <ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzYz_0241eefb-939c-491d-b6f0-1ab1dc7bc600">362-6295</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzU4_297df97c-95e1-481e-9723-b4dde71dc7d3">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communication pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzY1_06cf94e2-3342-44b6-9822-8d48ca5fb543">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzY2_5ad73686-0dcd-4587-ae12-6b39d5b20188">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communication pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzcy_efc3a04e-aef1-4eb5-8831-714c44a8dfbf">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communication pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.866%"><tr><td style="width:1.0%"></td><td style="width:35.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.870%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGFibGU6NzZjOTJlNzBhNjIyNGI0NTgwNDMxOTA5M2FkMzU2MjAvdGFibGVyYW5nZTo3NmM5MmU3MGE2MjI0YjQ1ODA0MzE5MDkzYWQzNTYyMF8xLTAtMS0xLTc2NjQy_5583df6d-083d-4af8-8569-c93ef0257004">Common Stock, par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGFibGU6NzZjOTJlNzBhNjIyNGI0NTgwNDMxOTA5M2FkMzU2MjAvdGFibGVyYW5nZTo3NmM5MmU3MGE2MjI0YjQ1ODA0MzE5MDkzYWQzNTYyMF8xLTEtMS0xLTc2NjQy_37beef68-3ad8-4e53-8293-69c39df00909">ANAB</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2.2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGFibGU6NzZjOTJlNzBhNjIyNGI0NTgwNDMxOTA5M2FkMzU2MjAvdGFibGVyYW5nZTo3NmM5MmU3MGE2MjI0YjQ1ODA0MzE5MDkzYWQzNTYyMF8xLTItMS0xLTc2NjQy_7c73d72f-a4d7-4a5a-acfe-4dc4d5a57d81">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib6630e3335bf43fca50df96f9aaf2922_D20230511-20230511" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmQ3ZTFkZjM2MjkwYjRjNDY4NzQ3NmQwOGUwMWNlOTU2L3NlYzpkN2UxZGYzNjI5MGI0YzQ2ODc0NzZkMDhlMDFjZTk1Nl8xL2ZyYWc6M2FkZjVlMmZiODYzNGUyNWExNmQ3Njg5MjJlNDhkNWMvdGV4dHJlZ2lvbjozYWRmNWUyZmI4NjM0ZTI1YTE2ZDc2ODkyMmU0OGQ1Y18xNzcz_023fd93a-a7c1-4658-9c4a-35bd267e06f9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id7e1df36290b4c4687476d08e01ce956_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:5pt;padding-left:63pt;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Item&#160;2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">On May 11, 2023, AnaptysBio, Inc. (&#8220;AnaptysBio&#8221;) issued a press release announcing its financial results for the three months ended March 31, 2023. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The information in this Item 2.02, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document filed by AnaptysBio with the Securities and Exchange Commission, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in such filing (or any reference to this Current Report on Form 8-K generally), except as shall be expressly set forth by specific reference in such filing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Item 9.01. &#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">(d) Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.106%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Exhibit Title or Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline" href="q12023earningsrelease.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Press release issued by AnaptysBio, Inc. regarding its financial results for the three months ended March 31, 2023, dated May 11, 2023.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">SIGNATURES</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  &#160;&#160;&#160;&#160;  </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AnaptysBio, Inc.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:  May 11, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">/s/Dennis Mulroy</span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Name: Dennis Mulroy</span></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Title: Chief Financial Officer</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "anab-20230511.htm", "description": "8-K", "secsgml_size_bytes": 32468}]
{"company-data": {"conformed-name": "ANAPTYSBIO, INC", "cik": "0001370053", "assigned-sic": "2834", "irs-number": "203828755", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37985", "film-number": "23911307"}, "business-address": {"street1": "10770 WATERIDGE CIRCLE, SUITE 210", "city": "SAN DIEGO", "state": "CA", "zip": "92121", "phone": "858-362-6295"}, "mail-address": {"street1": "10770 WATERIDGE CIRCLE, SUITE 210", "city": "SAN DIEGO", "state": "CA", "zip": "92121"}, "former-company": [{"former-conformed-name": "ANAPTYSBIO INC", "date-changed": "20080828"}, {"former-conformed-name": "ANAPTYS BIOSCIENCES INC", "date-changed": "20060724"}]}
anab-20230511
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report:
May 11, 2023
(Date of earliest event reported)
ANAPTYSBIO, INC
.
(Exact Name of Registrant as Specified in Charter)
Delaware
001-37985
20-3828755
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
10770 Wateridge Circle
,
Suite 210,
San Diego
,
CA
92121
(Address of Principal Executive Offices, and Zip Code)
(
858
)
362-6295
(Registrant's Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
ANAB
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02    Results of Operations and Financial Condition.
On May 11, 2023, AnaptysBio, Inc. ("AnaptysBio") issued a press release announcing its financial results for the three months ended March 31, 2023. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document filed by AnaptysBio with the Securities and Exchange Commission, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in such filing (or any reference to this Current Report on Form 8-K generally), except as shall be expressly set forth by specific reference in such filing.
Item 9.01.     Financial Statements and Exhibits
(d) Exhibits
Exhibit Number
Exhibit Title or Description
99.1
Press release issued by AnaptysBio, Inc. regarding its financial results for the three months ended March 31, 2023, dated May 11, 2023.
104
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
AnaptysBio, Inc.
Date:  May 11, 2023
By:
/s/Dennis Mulroy
Name: Dennis Mulroy
Title: Chief Financial Officer